Dexanabinol

DB06444InvestigationalSmall molecule

Investigated for use/treatment in traumatic brain injuries and neurologic disorders.

Chemical structure of Dexanabinol
Primary indication
Investigated for use/treatment in traumatic brain injuries and neurologic disorders.Curator reviewed
Formula / weight
C25H38O3 · 386.576 g/mol (avg)
Also known as
Sinnabidol
Code names
(+)-HU-210 · HU-211 · PA-50211 · PRS-211007 · PRS-211007-000

Resolves to

Compound
UNIIR6VT8U5372CAS112924-45-5ChEMBLCHEMBL334533PubChem107778
Structure
InChIKeySSQJFGMEZBFMNV-PMACEKPBSA-NSMILESCCCCCCC(C)(C)C1=CC(O)=C2[C@H]3CC(CO)=CC[C@@H]3C(C)(C)OC2=C1
Targets
P01375TNF

What you can answer from here — as of June 12, 2020

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexanabinol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In